Peripheral Vascular Devices Market, by Type (Angioplasty Balloon, Stent, Catheters, Plaque Modification, IVC Filters, Others), Region and Forecast, 2018 to 2028
Sep 2020
Total Pages: 150
Choose License Type
The global peripheral vascular devices market was valued at USD 9.0 billion in 2019 and is expected to grow at a CAGR of 6.8% over the forecast period. Growing geriatric population coupled with increase in prevalence of vascular diseases are key factors driving the growth of the global peripheral vascular devices market.
The rapid growth of the geriatric population is a significant driver of demand for peripheral vascular devices as the peripheral vascular disease such as atherosclerosis and aneurysms are more likely to occur in this segment of population. This is because genetic and lifestyle factors can lead to plaque buildup in the arteries, with age.
Key players serving the global peripheral vascular devices market include Medtronic Inc., Abbott, Edward Lifesciences Corporation, Teleflex Medical, Boston Scientific Corporation, Bayer, Terumo Interventional Systems Inc., BD, B. Braun Melsungen, Cardinal Health among other prominent players.
Key segments of the global peripheral vascular devices market
Type Overview, 2018-2028 (USD Billion)
- Angioplasty Balloon
- Stent
- Catheters
- Plaque Modification
- IVC Filters
- Others
Regional Overview, 2018-2028 (USD Billion)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- South America
- Brazil
- Mexico
- Rest of South America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East and Africa
Reasons for the study
- The purpose of the study is to give an exhaustive outlook of the global Peripheral Vascular Devices industry
- The overall segmentation of peripheral vascular devices market, especially key segments are thoroughly studied.
- Presence of major players and their wide product portfolio across developed countries is anticipated to further boost the growth of peripheral vascular devices market
What does the report include?
- The study on the global peripheral vascular devices market includes analysis of qualitative market indicators such as drivers, restraints, challenges and opportunities
- Additionally, the market competition has been evaluated using the Porter’s five forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of applications, product, technology and end user. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the considered segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global peripheral vascular devices market is suitable for all the players across the value chain including raw material suppliers, Peripheral Vascular Devices providers, medical device manufacturers, distributors, suppliers and retailers
- Venture capitalists and investors looking for more information on the future outlook of the global peripheral vascular devices market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global peripheral vascular devices market
The worldwide growing prevalence of venous diseases or CVI is expected to drive the global peripheral vascular device market. Some of the other factors in this market include the growing global geriatric population base, which induces target disease incidence rates , increased demand for minimally invasive endovascular procedures due to a shorter recovery period, a less terrifying and a lower risk of postoperative infection. Additionally, rising prevalence of lifestyles disease (such as high intake of alcohol, tobacco) is expected to raise the demand for peripheral vascular devices market by triggering the incidence of cardiac arrest, blood clotting and other vascular diseases.
The global peripheral vascular devices market has been segmented based on type into angioplasty balloon, stent, catheters, plaque modification, IVC Filters among others. A variety of forms of stents are available on the market including a drug-eluting stent, a bare-metal stent, a bio-absorbable stent, a sealed stent, a dual-therapy stent and a bio-engineered stent. The use of ballon angioplasty uses more peripheral stents to expand the veins so that blood can pass into the blocked veins in the body and is often used to revision aneurysm. Stents and balloons play the largest role of the demand for peripheral vascular devices. Peripheral transluminal angioplasty balloon catheters sometimes referred to as angioplasty, a catheter is put into the veins of the thigh, wrist or sides, helping to prevent blood clotting. Atherectomy is a minimally invasive type of procedure used to remove atherosclerosis from the body's large blood vessels.
Based on regions, the global peripheral vascular devices market is segmented into North America, Europe, Asia Pacific, South America and Middle East & Africa. Some of the factors that lead to its disproportionate share are higher acceptance rates for minimally invasive surgery along with a high level of patient recognition and health care expenses. Because of the significant number of patients with unsupported medical needs, Asia Pacific is projected to be the most lucrative regional market for peripheral vascular products from 2020 to 2028. In addition, the rapid development of health infrastructure and increasing patient disposable incomes in emerging markets, such as India and China, should be a potential growth in the overall sector.
The global peripheral vascular devices market was valued at USD 9.0 billion in 2019 and is expected to grow at a CAGR of 6.8% over the forecast period. Growing geriatric population coupled with increase in prevalence of vascular diseases are key factors driving the growth of the global peripheral vascular devices market.
The rapid growth of the geriatric population is a significant driver of demand for peripheral vascular devices as the peripheral vascular disease such as atherosclerosis and aneurysms are more likely to occur in this segment of population. This is because genetic and lifestyle factors can lead to plaque buildup in the arteries, with age.
Key players serving the global peripheral vascular devices market include Medtronic Inc., Abbott, Edward Lifesciences Corporation, Teleflex Medical, Boston Scientific Corporation, Bayer, Terumo Interventional Systems Inc., BD, B. Braun Melsungen, Cardinal Health among other prominent players.
Key segments of the global peripheral vascular devices market
Type Overview, 2018-2028 (USD Billion)
- Angioplasty Balloon
- Stent
- Catheters
- Plaque Modification
- IVC Filters
- Others
Regional Overview, 2018-2028 (USD Billion)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- South America
- Brazil
- Mexico
- Rest of South America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East and Africa
Reasons for the study
- The purpose of the study is to give an exhaustive outlook of the global Peripheral Vascular Devices industry
- The overall segmentation of peripheral vascular devices market, especially key segments are thoroughly studied.
- Presence of major players and their wide product portfolio across developed countries is anticipated to further boost the growth of peripheral vascular devices market
What does the report include?
- The study on the global peripheral vascular devices market includes analysis of qualitative market indicators such as drivers, restraints, challenges and opportunities
- Additionally, the market competition has been evaluated using the Porter’s five forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of applications, product, technology and end user. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the considered segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global peripheral vascular devices market is suitable for all the players across the value chain including raw material suppliers, Peripheral Vascular Devices providers, medical device manufacturers, distributors, suppliers and retailers
- Venture capitalists and investors looking for more information on the future outlook of the global peripheral vascular devices market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global peripheral vascular devices market
Chapter 1. Introduction
1.1. Introduction to the Study
1.2. Market Definition and Scope
1.3. Units, Currency, Conversions and Years Considered
1.4. Key Stakeholders
1.5. Key Questions Answered
Chapter 2. Research Methodology
2.1. Introduction
2.2. Data Capture Sources
2.3. Primary Sources
2.4. Secondary Sources
2.5. Market Size Estimation
2.6. Market Forecast
2.7. Data Triangulation
2.8. Assumptions and Limitations
Chapter 3. Market Outlook
3.1. Introduction
3.2. Macroeconomic Indicators
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.3.4. Challenges
3.4. Porter’s Five Forces Analysis
3.5. PESTLE Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Global Peripheral Vascular Devices Market by Type, 2018-2028 (USD Billion)
4.1.1. Angioplasty Balloon
4.1.2. Stent
4.1.3. Catheters
4.1.4. Plaque Modification
4.1.5. IVC Filters
4.1.6. Others
Chapter 5. Global Peripheral Vascular Devices Market by Region, 2018-2028 (USD Billion)
5.1. North America
5.1.1. U.S.
5.1.2. Canada
5.2. Europe
5.2.1. Germany
5.2.2. UK
5.2.3. France
5.2.4. Spain
5.2.5. Rest of Europe
5.3. Asia Pacific
5.3.1. Japan
5.3.2. China
5.3.3. India
5.3.4. Rest of Asia Pacific
5.4. South America
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of South America
5.5. Middle East and Africa
5.5.1. GCC
5.5.2. South Africa
5.5.3. Rest of Middle East and Africa
Chapter 6. Company Profiles
6.1. Medtronic Inc.
6.1.1. Overview
6.1.2. Products and Services Portfolio
6.1.3. Recent Initiatives
6.1.4. Company Financials
6.2. Abbott
6.2.1. Overview
6.2.2. Products and Services Portfolio
6.2.3. Recent Initiatives
6.2.4. Company Financials
6.3. Edward Lifesciences Corporation
6.3.1. Overview
6.3.2. Products and Services Portfolio
6.3.3. Recent Initiatives
6.3.4. Company Financials
6.4. Teleflex Medical
6.4.1. Overview
6.4.2. Products and Services Portfolio
6.4.3. Recent Initiatives
6.4.4. Company Financials
6.5. Boston Scientific Corporation
6.5.1. Overview
6.5.2. Products and Services Portfolio
6.5.3. Recent Initiatives
6.5.4. Company Financials
6.6. Bayer
6.6.1. Overview
6.6.2. Products and Services Portfolio
6.6.3. Recent Initiatives
6.6.4. Company Financials
6.7. Terumo Interventional Systems Inc.
6.7.1. Overview
6.7.2. Products and Services Portfolio
6.7.3. Recent Initiatives
6.7.4. Company Financials
6.8. BD
6.8.1. Overview
6.8.2. Products and Services Portfolio
6.8.3. Recent Initiatives
6.8.4. Company Financials
6.9. B. Braun Melsungen
6.9.1. Overview
6.9.2. Products and Services Portfolio
6.9.3. Recent Initiatives
6.9.4. Company Financials
6.10. Cardinal Health
6.10.1. Overview
6.10.2. Products and Services Portfolio
6.10.3. Recent Initiatives
6.10.4. Company Financials
Chapter 7. Appendix
7.1. Primary Research Approach
7.1.1. Primary Interview Participants
7.1.2. Primary Interview Summary
7.2. Questionnaire
7.3. Related Reports
7.3.1. Published
7.3.2. Upcoming